Inovio Pharmaceuticals (INO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Inovio Pharmaceuticals (INO) over the last 15 years, with Q3 2025 value amounting to -$7.0 million.
- Inovio Pharmaceuticals' Other Gross PP&E Adjustments rose 1789.33% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year increase of 1789.33%. This contributed to the annual value of $8.9 million for FY2024, which is 2919.52% down from last year.
- According to the latest figures from Q3 2025, Inovio Pharmaceuticals' Other Gross PP&E Adjustments is -$7.0 million, which was up 1789.33% from -$7.4 million recorded in Q2 2025.
- Inovio Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $21.2 million for Q4 2021, and its period low was -$12.8 million during Q1 2021.
- Over the past 5 years, Inovio Pharmaceuticals' median Other Gross PP&E Adjustments value was -$9.1 million (recorded in 2023), while the average stood at -$4.7 million.
- As far as peak fluctuations go, Inovio Pharmaceuticals' Other Gross PP&E Adjustments soared by 8711.9% in 2021, and later crashed by 2919.52% in 2024.
- Over the past 5 years, Inovio Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $21.2 million in 2021, then fell by 28.78% to $15.1 million in 2022, then decreased by 16.4% to $12.6 million in 2023, then fell by 29.2% to $8.9 million in 2024, then crashed by 177.74% to -$7.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$7.0 million in Q3 2025, compared to -$7.4 million in Q2 2025 and -$7.7 million in Q1 2025.